Consortium for the Evaluation and Performance of HIV Incidence Assays hosts webinar on ‘Recent Infection’ and the CEPHIA development pipeline for incidence assays.

On 12 November 2013, CEPHIA hosted a webinar bringing together the Bill and Melinda Gates Foundation supported teams involved in biomarker discovery projects for incidence assay development. Alex Welte presented an outline of the basic ideas about the definition and calibration of ‘recent infection’ using biomarkers, and Chris Pilcher presented CEPHIA’s framework for the pathway from biomarker discovery to assay evaluation.

The slides are here for Alex Welte and here for Chris Pilcher.